Branch of Guangzhou Baiyunshan Pharmaceutical Holdings (00874), Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical General Factory has obtained drug supplementary application approval.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that its subsidiary Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Group Co., Ltd. (referred to as "Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory") recently received the "Drug Supplementary Application Approval Notification" issued by the National Medical Products Administration. The announcement stated that Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory has obtained the "Drug Supplementary Application Approval Notification" for Fuke'an Tablets, Kunling Pills, Shenxi Dan, Yiganling Tablets, and Maian Granules, which enhances the safety information of these drugs and contributes to their safe, effective, and rational use, thereby improving the market competitiveness of the products. The receipt of the "Drug Supplementary Application Approval Notification" this time will not have a significant impact on the company's current performance.